Jennifer Cochran and Amato Giaccia led a team of researchers who have developed an experimental therapy to treat metastatic cancer. (Photo: Rod Searcey)
Experimental therapy stopped the metastasis of breast and ovarian cancers in lab mice, pointing toward a safe and effective alternative to chemotherapy.
A team of Stanford researchers has developed a protein therapy that disrupts the process that causes cancer cells to break away from original tumor sites, travel through the bloodstream and start aggressive new growths elsewhere in the body.
This process, known as metastasis, can cause cancer to spread with deadly effect.
“The majority of patients who succumb to cancer fall prey to metastatic forms of the disease,” said Jennifer Cochran, an associate professor of bioengineering who describes a new therapeutic approach in Nature Chemical Biology.
Today doctors try to slow or stop metastasis with chemotherapy, but these treatments are unfortunately not very effective and have severe side effects.
The Stanford team seeks to stop metastasis, without side effects, by preventing two proteins – Axl and Gas6 – from interacting to initiate the spread of cancer.
Axl proteins stand like bristles on the surface of cancer cells, poised to receive biochemical signals from Gas6 proteins.
When two Gas6 proteins link with two Axls, the signals that are generated enable cancer cells to leave the original tumor site, migrate to other parts of the body and form new cancer nodules.
To stop this process Cochran used protein engineering to create a harmless version of Axl that acts like a decoy. This decoy Axl latches on to Gas6 proteins in the bloodstream and prevents them from linking with and activating the Axls present on cancer cells.
In collaboration with Professor Amato Giaccia, who leads the Radiation Biology Program in the Stanford Cancer Center, the researchers gave intravenous treatments of this bioengineered decoy protein to mice with aggressive breast and ovarian cancers.
Mice in the breast cancer treatment group had 78 percent fewer metastatic nodules than untreated mice. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein.
“This is a very promising therapy that appears to be effective and nontoxic in preclinical experiments,” Giaccia said. “It could open up a new approach to cancer treatment.”
The Latest on: Alternative to chemotherapy
Neoadjuvant Chemo Safer Alternative for Certain Patients With Ovarian Cancer - OncLive
August 28, 2019 - Neoadjuvant Chemo Safer Alternative for Certain Patients With Ovarian Cancer OncLiveAlthough upfront debulking surgery is standard for most patients with advanced ovarian cancer, neoadjuvant chemotherapy potentially offers a less morbid ...Noah McAdams’ mom: Family was ‘looking for alternative treatments’ to chemo - WFLA
August 20, 2019 - Noah McAdams’ mom: Family was ‘looking for alternative treatments’ to chemo WFLATAMPA, Fla. (WFLA) – The mother of Noah McAdams testified in court Tuesday and said she and her husband sought “alternative treatments” instead of ...
Alternatives for Bladder Cancer Tx During Ongoing BCG Shortage - Medscape
September 6, 2019 - Alternatives for Bladder Cancer Tx During Ongoing BCG Shortage MedscapeThe ongoing shortage of bacillus Calmette-Guérin (BCG), used intravesically to treat early-stage bladder cancer, continues to motivate experts to identify ...Six things to know about cancer: From suicidal cells to hair loss from chemotherapy - Medical Xpress
September 4, 2019 - Six things to know about cancer: From suicidal cells to hair loss from chemotherapy Medical XpressNews of the discovery of herbal cancer treatments has always piqued people's interest. Recently, the media in Indonesia extensively reported claims of a cancer ...
WCLC: Merck analyses throw doubt on new biomarker's utility - FiercePharma
September 8, 2019 - WCLC: Merck analyses throw doubt on new biomarker's utility FiercePharmaLooking to find their niche in the ultra-lucrative non-small cell lung cancer market, some immuno-oncology companies have turned to investigational biomarker ...Equashield and Tosho Inc. Increase CSTD Adoption in Japan - PR Newswire UK
September 8, 2019 - Equashield and Tosho Inc. Increase CSTD Adoption in Japan PR Newswire UKNew Agreement with PAL Medical Expands Availability of Equashield's Award Winning CSTD to Include Japanese Oncology Nurses NEW YORK, Sept. 8, 2019 ...
Bowel cancer: 3-drug combo may offer alternative to chemo - Medical News Today
July 14, 2019 - Bowel cancer: 3-drug combo may offer alternative to chemo Medical News TodayBy combining three different drugs, researchers may have found a potential alternative to chemotherapy as a treatment for an advanced form of bowel cancer.
How yoga has helped this Bellville breast cancer survivor - Richland Source
September 8, 2019 - How yoga has helped this Bellville breast cancer survivor Richland SourceBELLVILLE — Yoga is touted as one of the best forms of physical activity, with numerous health benefits.September 5, 2019 - Attorneys Argue Over Whether Philip Morris Cigarettes Caused Massachusetts Woman's Cancer, as Trial Begins CVN NewsPhilip Morris's design of its Marlboro cigarettes ultimately caused a Massachusetts woman's lung cancer, an attorney for the woman told jurors Thursday, as trial ...
NIH funding to support research into cancer treatment monitoring - Phys.Org
September 5, 2019 - NIH funding to support research into cancer treatment monitoring Phys.OrgA grant from the National Institutes of Health will support a biomedical engineering professor's pursuit of technologies that can identify treatment-resistant tumors ...
via Google News
The Latest on: Alternative to chemotherapy
- More targeted, less toxic: The golden future of cancer treatmenton September 6, 2019 at 12:11 am
said the limitations of commonly used metal-based chemotherapies drove a need to find better alternatives. "We've made huge inroads in cancer treatment over recent decades, but the disease still ...
- NIH funding to support research into cancer treatment monitoringon September 5, 2019 at 7:08 am
The current standard of care is to treat these tumors with a seven-week regimen of radiation and chemotherapy. Follow-up clinical ... both responsive and resistant - to lose critical time when ...
- Henry Ford Cancer Institute first-in-Michigan, second-in-world to complete SLITTon September 4, 2019 at 2:12 pm
For Jacquelyn Donley, SLITT was a promising alternative treatment option for what would otherwise ... she underwent radiation and chemotherapy treatments. These were effective for her until 2017, when ...
- Six things to know about cancer: from suicidal cells to hair loss from chemotherapyon September 3, 2019 at 9:42 pm
Recently, the media in Indonesia extensively reported claims of a cancer cure made from a plant native to Borneo and the use of soursop leaves as a form of alternative treatment. This is not ...
- Valerie Harper’s Net Worth: 5 Fast Facts You Need to Knowon August 30, 2019 at 10:03 pm
Valerie Harper’s cancer treatment cost $3 million since her diagnosis in 2013. Her treatment included alternative treatments and experimental drugs. She was given only three months to live in ...
- Cancer Resource Centers of Mendocino County: Complementary and alternative therapieson August 29, 2019 at 2:27 pm
At the Cancer Resource Centers of Mendocino County, our clients frequently explore complementary and alternative therapies as a way to reduce the physical side effects of cancer treatment or cope with ...
- Cervical Cancer: NAC Plus CRT Inferior to CRT Aloneon August 29, 2019 at 1:45 pm
The addition of neoadjuvant chemotherapy (NAC) using the combination of cisplatin ... "It is imperative to continue studying other treatment strategies to improve outcomes, as well as alternatives to ...
- Neoadjuvant Chemo Safer Alternative for Certain Patients With Ovarian Canceron August 28, 2019 at 1:16 pm
Although upfront debulking surgery is standard for most patients with advanced ovarian cancer, neoadjuvant chemotherapy potentially offers a less morbid alternative for those who are ineligible for ...
- 3 Cancer Treatment Stocks to Enrich Your Portfolioon August 27, 2019 at 7:15 am
Cancer treatment is one of the hottest areas of ... Exact Sciences Corporation EXAS, thus, came up with Cologuard in 2014 as an alternative to a colonoscopy. Not much cost is involved and the ...
- Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung canceron August 27, 2019 at 5:36 am
Chemotherapy regimens produce side effects with different ... side effects is because they wish to avoid leaving a spouse alone in case of their demise. An alternative possibility relates to the ...
via Bing News
